Application of BST-2 protein in preparing medicaments for treating diseases caused by influenza A virus

A type of influenza A virus, BST-2 technology, applied in the application field of infection and release, can solve the problems of unseen influenza virus particle release and replication impact, etc.

Inactive Publication Date: 2013-09-18
MEDICINE & BIOENG INST OF CHINESE ACAD OF MEDICAL SCI
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Influenza virus is also an enveloped virus, but there is no report on the effect of BST-2 on the release and replication of influenza virus particles

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of BST-2 protein in preparing medicaments for treating diseases caused by influenza A virus
  • Application of BST-2 protein in preparing medicaments for treating diseases caused by influenza A virus
  • Application of BST-2 protein in preparing medicaments for treating diseases caused by influenza A virus

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] experiment material

[0031] 1. Main instruments

[0032]

[0033] 2. Plasmid

[0034] 1) Influenza A virus (IAV) reverse genetic eight plasmid system according to literature (Hoffmann, E., et al., A DNA transfection system for generation of influenza A virus from eight plasmids.Proc Natl Acad Sci U S A, 2000.97 (11 ): p.6108-13), respectively: pHW181-PB2, pHW182-PB1, pHW183-PA, pHW184-HA, pHW185-NP, pHW186-NA, pHW187-M, pHW188-NS. The vectors used in this plasmid system are all pHW2000, and the viral cDNA is inserted between the RNA polymerase I (pol I) promoter and the terminator sequence; the transcription unit of pol I is located between the RNA polymerase II (pol II) promoter and the polyA sequence between. In cells, viral negative-strand RNA and mRNA can be synthesized, followed by viral protein synthesis, and finally assembled into infectious influenza virus particles.

[0035] 2) shRNA plasmids were purchased from Sigma

[0036]

[0037] 3) Plasmid pH...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses an application of a BST-2 protein in preparing medicaments for treating diseases caused by influenza A virus. The BST-2 protein can inhibit IAV viral infection and prevent budding and releasing of the IAV virus from host cell surfaces through inhibiting expression of IAV virus M2 protein and interacting with the M2 protein. According to the invention, the BST-2 protein will become a new target for anti-influenza drugs, paves the way for research and development of the anti-influenza drugs in the future, and may even provide a potential therapeutic approach for treatment of the influenza.

Description

technical field [0001] The invention belongs to the field of biomedicine and relates to the application of BST-2 in inhibiting the infection and release of influenza A virus. Background technique [0002] Influenza A virus is a common influenza virus that can cause outbreaks of seasonal and regional influenza. Influenza A virus has a wide range of hosts, including pigs, horses, leopards, marine mammals (seals, whales) and birds in addition to humans. The surface antigens HA and NA of influenza A virus are more likely to mutate, so it is easy to cause a large-scale epidemic. For example, the Spanish flu in 1918 was caused by influenza A virus (H1N1), causing about 20 million deaths. In 2009, the global epidemic caused by influenza A virus (H1N1) caused 18,500 deaths worldwide. Influenza A virus therefore poses a serious threat to public health worldwide. [0003] Influenza A Virus (IAV) belongs to the Orthomyxoviridae family and is an enveloped virus containing 8 segments ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/19A61P31/16
Inventor 岑山
Owner MEDICINE & BIOENG INST OF CHINESE ACAD OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap